Skip to content

Evaluating Quebec's Red-Cross Intervention

Seniors Waiting for Medico-social Care at the CIUSSS-Centre-Sud de l'île de Montréal's Territory Waiting List (GACO) : Evaluation of the Intervention of a New Partner - Quebec's Red-Cross

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05099042
Enrollment
300
Registered
2021-10-29
Start date
2021-06-28
Completion date
2022-07-27
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Social Isolation

Brief summary

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 to 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) concludes that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.

Interventions

OTHERRecommendations and re-orientation towards appropriate physical, mental, and social health ressources

Resources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP.

Sponsors

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 65 and more * Living at home * Be registered at the waiting list of GACO at the CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL)

Exclusion criteria

* Principal address outside of the CCSMTL territory * Participate at another clinical trial, to avoid interferences * Not understand written or spoken French or English, questionnaires are only available in French and English.

Design outcomes

Primary

MeasureTime frameDescription
Social health measured through a questionnaire3 monthsIssues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)
COVID-19 symptoms assessed through a questionnaire3 monthspresence or not of fever, cough, and shortness of breath (binary question)
psychological fraility3 monthsAnxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious
Autonomy3 monthsADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.
Socio-economic characteristics3 monthsPresence or not of socio-economic problems (binary questions)
Participant's Quality of life3 monthsMeasured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.

Secondary

MeasureTime frameDescription
Caregiver burden3 monthsBased on Zarit scale, score from 0= no burden to 16= high caregiver burden

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026